Actively Recruiting

Phase Not Applicable
Age: 22Years - 75Years
All Genders
ID07357428

Connect-One: Early Feasibility Study of Connexus4 Brain-Computer Interface (BCI) to Provide Human Connection Through Communication

Led by Paradromics · Updated on 2026-04-14

2

Participants Needed

3

Research Sites

243 weeks

Total Duration

On this page

Sponsors

P

Paradromics

Lead Sponsor

U

University of Michigan

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the Connexus Brain-Computer Interface (BCI) in an early feasibility study to gather initial safety data. The Connexus BCI is designed to help people with severe loss of voluntary motor control, enabling communication by decoding imagined language and speech. It also aims to assist with controlling computer devices for individuals with impaired upper limb function due to conditions like amyotrophic lateral sclerosis, stroke, or spinal cord injury. The study involves implanting the Connexus Brain-Computer Interface device, which is an implantable technology. Participants will use the device to explore its potential as an assistive communication tool and control aid. The study will monitor safety outcomes related to the device over periods extending up to 12 months initially and up to 6 years for long-term safety. Participants will be closely followed with assessments focusing on device-related adverse events. The research team will evaluate both primary safety within the first year after implantation and long-term safety over several years. Participants will need a care partner and live within a reasonable distance from the study site to support their involvement throughout the study duration.

CONDITIONS

Brief Title

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

Who Can Participate

Age: 22Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of a progressive neuromuscular disease or a neurological injury
  • Clinical diagnosis of anarthria or severe dysarthria
  • Wheelchair dependent with severely impaired upper limb function
  • Has a reliable method of communication and the ability to read and understand the English language
  • Has a study care partner (e.g. caregiver or multiple caregivers) for the duration of the study
  • Lives within a 4-hour radius of a study site
Not Eligible

You will not qualify if you...

  • Cognitive impairment or psychiatric illness that could impact the ability to comply with study requirements, as determined by the Study Investigator
  • Co-morbidities or an ongoing chronic medical condition that would impair the ability to comply with study requirements
  • The presence of another implanted device, like a pacemaker, deep brain stimulator, or implantable pulse generator
  • Requires, or is expected to require regular MRI scans for on-going medical conditions
  • In the opinion of the Study Investigator, the patient is not an appropriate candidate for the study, for reasons that could place the patient at undue risk or otherwise result in non-compliance with the study requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 1 day

Participants undergo implantation of the Connexus Brain-Computer Interface device.

1 implantation visit (in-person)

Post-operative Follow-up

Duration - Up to 12 months post-implant

Participants are monitored for device safety and function after implantation.

Regular follow-up visits during the first year

Long-term Monitoring

Duration - Up to 6 years post-implant

Participants are followed for long-term device safety and outcomes.

Periodic visits over 6 years

Trial Site Locations

Total: 3 locations

1

University of California, Davis

Sacramento, California, United States, 95817

Actively Recruiting

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

3

University of Michigan

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

Loading map...

Research Team

P

Paradromics Clinical Team

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Efficacy and Target Engagement of a Digital Intervention to ...

Executive Dysfunction

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here